Sign up to be the first to receive all the latest IgA nephropathy news and updates

Stay connected with Calliditas: a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing novel treatments in orphan indications, with an initial focus on renal and hepatic diseases with significant unmet medical needs.

    Hear more from a medical science liaison

    IgA=immunoglobulin A; IgAN=immunoglobulin A nephropathy; MOD=mechanism of disease.